Pay in installments of $6.15 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 17 - Jul 22
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
Eli Lilly Introduces New Zepbound Weight Loss Drug Doses, Lowers Price Points WSJ Mounjaro in The Netherlands : r Mounjaro How fast does Zepbound work? Mental Health Effects of Tirzepatide: A Report of 2 Patients Tirzepatide Injection in Singapore: Where to Buy and Cost Guide The Clifford Clinic Tirzepatide Erectile Dysfunction: Exploring the Metabolic Connection and Support Options
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.2 ★★★★★
Based on 25 reviews
Sort
Product Reviews
★★★★★ 2
A disappointing "Dark Droids" tie-in.
Format: Paperback
A tie-in miniseries-of-sorts to the main “Dark Droids” event, “Star Wars: Dark Droids: D-Squad” is, unfortunately, all too characteristic of typical comic book event “addendums”: lots of flash, little substance. To be fair, writer Marc Guggenheim does what he can to flesh out the core story, which involves a squad of droids, all of whom are pulled from the various ongoing “Star Wars” titles – forming the titular “D-Squad” – to take on the Scourge threat from the main “Dark Droids” event. The problem is that too much of the series feels like it’s spinning in circles – there’s a frustrating lack of narrative momentum here, and the result is a story that, frustratingly, revs to life only in spurts.
Not a terrible comic, but considering the overall quality of the “Dark Droids” event as a whole, a disappointing one.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 9, 2024
★★★★★ 5
Extremely Satisfied
This is a gift for my daughter and I looked at it making sure it works base on former reviews. At first the lid wouldn’t close and it was extremely disappointed but my husband laughed and said hold the lid and turn the handle. It then will latch and stay close. So now I’m extremely satisfied lol
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 28, 2026
★★★★★ 5
Classic Toy That Never Gets Old!
My 8-month-old is absolutely captivated by this Elmo jack-in-the-box! She giggles with anticipation as the "Waltzing Matilda" tune plays, and erupts in laughter when the soft Elmo plush pops out. The sturdy metal box with vibrant Sesame Street designs has held up perfectly through daily play. At 5.25 x 5.25 x 5.5 inches, it's the perfect size for little hands. This timeless toy brings endless joy and smiles—highly recommend for any Elmo-loving baby or toddler!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 27, 2025
★★★★★ 5
Kids love it.
The kids love it. good 18 month baby toy.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 22, 2026
★★★★★ 5
Elmo -in-a- Box !
Purchased as a gift for my grand daughter who happens to love Elmo. Cute toy with a little red Elmo who pops up and makes you jump if you’re not expecting it. It’s still working since December so that’s a good sign !
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 2, 2026
recommand products
semaglutide fda approval date FDA approves first-ever oral GLP-1RA for obesity and chronic weight management. Meet Wegovy (semaglutide) tablets. https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-wegovy-pill-the-first-and-only-oral-glp
27.94
Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients
24.51
🎉Exciting news that Semaglutide is now FDA approved for MASH (aka fatty liver disease) “At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63%
25.50
A New Indication for Semaglutide (Wegovy) https://bit.ly/3UmgXaj The injectable glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy) has been approved by the FDA to reduce the risk…
23.95
Navigating Compounded Semaglutide: What Health Care Providers Need to Know
20.59